Artivion Inc (AORT) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide.
Total Assets Chart for Artivion Inc
Artivion Inc (AORT) total assets for FY2025 were USD 884.8M, a 12.1% change from FY2024. Artivion Inc's total assets grew from USD 10.9M in 1991 to USD 884.8M in 2025 (8017.4% over 34 years). Total assets compound annual growth rate: 5-year CAGR of 2.3%, 10-year CAGR of 17.2%, 20-year CAGR of 13.0%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $1.14B
- Implied Share Price
- $23.30
- Enterprise Value
- $1.49B
- Revenue (TTM)
- $471.47M
- EBITDA
- $63.72M
- Profit Margin
- -0.67%
- Trailing P/E
- —
- Forward P/E
- 35.97
- Price/Book (MRQ)
- 2.61
- Price/Sales (TTM)
- 2.41
- EV/EBITDA
- 29.28
- EV/Revenue
- 3.17
- Dividend Yield
- —
- Book Value
- $9.15
- Free Cash Flow (FY2025)
- -$911,000.00
- Free Cash Flow Yield
- -0.08%
Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.